NPPB and AL amyloidosis: Palladini et al.49 demonstrated that post-treatment NT-proBNP response independently predicted patient survival in a study of 113 patients with AL amyloidosis treated primarily with MDex, Dex, cyclophosphamide plus thalidomide and dexamethasone (CyTDex) or ASCT.